Erasmus Medical Center — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Erasmus Medical Center appears in 151 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials151

Recruiting shown10

Roles2

SourceClinicalTrials.gov

Clinical trials

60 shown

Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III)NCT07161869 · lead sponsor · 2026-02-05

FCV vs VCV in Obstructive and Asthmatic PatientsNCT06563544 · lead sponsor · 2025-01-17

Additional Chemotherapy Administered Directly Into the Liver Using a Chemo Pump in Patients With Bile Duct Cancer Inside the Liver Treatable by SurgeryNCT06888063 · lead sponsor · 2024-11-20

Data Collection in Lutetium Treated Prostate Cancer: Recording of Progression and Tumor CharacteristicsNCT06260410 · lead sponsor · 2024-02-20

Docetaxel or Cabazitaxel With or Without Darolutamide in mCRPCNCT05762536 · lead sponsor · 2023-11-29

Safety and Efficacy of Ultrasound Renal Denervation in Kidney Transplantation Patients With Uncontrolled HypertensionNCT05934383 · lead sponsor · 2023-09-04

dENdritic Cell Therapy Combined With SURgEry in MesotheliomaNCT05304208 · lead sponsor · 2021-11-02

FUnctional Selection of Advanced Breast Cancer Patients for Talazoparib Treatment Using the REpair Capacity (RECAP) TestNCT06193525 · lead sponsor · 2019-09-16

ProSpecTive sAmpling in dRiver muTation Pulmonary Oncology Patients on Tyrosine Kinase Inhibitors (START-TKI)NCT05221372 · lead sponsor · 2017-02-02

Ex Vivo Characterization and Targeting of the Latent HIV Infected Reservoir to Cure HIVNCT05215704 · lead sponsor · 2012-01-01

Biomarkers for Post-treatment Control in HIV: International Study of the EU2Cure Research Consortium (Phase I)NCT07692295 · lead sponsor · 2026-10-01

NOT_YET_RECRUITING

Sweet & Sour: Dietary Acid Load in Type 2 Diabetes and Kidney Disease Across Sex and Ethnic GroupsNCT07587918 · lead sponsor · 2026-06-01

NOT_YET_RECRUITING

Combining Latency Reversing Agents to Address the HIV ReservoirNCT07384624 · lead sponsor · 2026-04-01

NOT_YET_RECRUITING

Multivitamin Impact on Micronutrient Status in GLP-1 Users: A Randomized TrialNCT07234916 · lead sponsor · 2025-12-16

ENROLLING_BY_INVITATION

Studying Topiramate for Re-Activating the HIV-1 ReservoirNCT06282783 · lead sponsor · 2024-09-01

Mobile Screening for Major Depressive Disorder in Adults From an Ethnically and Socioeconomically Diverse Population.NCT05989412 · lead sponsor · 2024-09-01

ACTIVE_NOT_RECRUITING

REMAP ECMO - Beta Receptor Modulation TrialNCT06522594 · lead sponsor · 2024-06-01

Clinical Effects of Intra-aortic Balloon Support in Early Acute Coronary Syndrome and Non-Acute Coronary Syndrome Related Cardiogenic ShockNCT06414187 · lead sponsor · 2024-06-01

NOT_YET_RECRUITING

Optimizing Reversal of HIV Latency With Combination TherapyNCT06240520 · lead sponsor · 2024-04-01

The Effect of a Laryngeal Mask Airway on Optic Nerve Sheath DiameterNCT06403592 · lead sponsor · 2024-03-25

INTRUSION: Unraveling the INTRatUmoral PK/PD relatION for SAR408701NCT05703555 · lead sponsor · 2024-02-16

Evaluating the Incidence of Pseudo-Acute Kidney Injuries in Patients With Metastatic Breast Cancer on CDK4/6 Inhibitors Trough Cystatin C AnalysisNCT06338605 · lead sponsor · 2023-12-12

Dietary Restriction to Prevent Cardiotoxicity in Breast Cancer PatientsNCT06622954 · lead sponsor · 2023-05-10

Growth Hormone Study in Adults With Prader-Willi SyndromeNCT04484051 · lead sponsor · 2023-03-24

REducing Stress and Improving professionaLs' vItality Using innovativE iNtervenTionsNCT06035666 · lead sponsor · 2023-01-01

Multiple-biomarker Approach for Individualized Treatment of Heart Failure With Preserved Ejection FractionNCT06785506 · lead sponsor · 2022-11-25

ACTIVE_NOT_RECRUITING

Real-time Pressure Volume Loop Monitoring as a Guide for Enhanced Understanding of Changes in Elemental Cardiovascular Physiology During Therapeutic Strategies Aiming for Hemodynamic Optimization. Cohort II: Structural Heart Interventions (PLUTO-II)NCT06204783 · lead sponsor · 2022-11-14

Real-time Pressure Volume Loop Monitoring as a Guide for Enhanced Understanding of Changes in Elemental Cardiovascular Physiology During Therapeutic Strategies Aiming for Hemodynamic Optimization. Cohort I: Veno-arterial Extracorporeal Membrane Oxygenation (PLUTO-I)NCT05909280 · lead sponsor · 2022-11-14

Tamoxifen Prediction Study in Patients With ER+ Breast CancerNCT05525481 · lead sponsor · 2022-11-01

The Microbiome in (Non-) Obese Pregnancy and Pregnancy OutcomesNCT05754645 · lead sponsor · 2022-07-21

A First Step Towards Ultra-hypofractionation for Unfavourable Intermediate and High-risk Prostate CancerNCT05361902 · lead sponsor · 2022-07-07

ACTIVE_NOT_RECRUITING

Guideline Implementation and Quality of Care in Patients With Heart Failure: the TITRATE-HF RegistryNCT06386042 · lead sponsor · 2022-06-05

ACTIVE_NOT_RECRUITING

An Integrated Optimization of Surgery and Radiotherapy Techniques to Improve Cosmetic Outcome and Quality of Life in Breast Conserving Therapy for Breast Cancer Patients (STARLINGS Study)NCT05263362 · lead sponsor · 2022-04-11

Treatment of Vascular Stiffness in ADPKDNCT05228574 · lead sponsor · 2022-03-11

Actium-225-Prostate Specific Membrane Antigen Imaging & TherapyNCT05902247 · lead sponsor · 2021-12-29

The Effect of Progressive Resistance Exercise Training (PRET) on CVRF in Adults With ID.NCT06579898 · lead sponsor · 2021-12-01

TEIPP Immunotherapy in Patients With NSCLCNCT05898763 · lead sponsor · 2021-09-29

PCT-guided Treatment Regarding Antibiotic Use for Acute COPD ExacerbationsNCT05854901 · lead sponsor · 2021-08-10

A Prospective Cohort for ex Vivo Cure Studies With Chronic HIV Infected Patients in the NetherlandsNCT04888754 · lead sponsor · 2021-05-26

ACTIVE_NOT_RECRUITING

HIV/COV in Ukraine-NLNCT04711954 · lead sponsor · 2020-11-01

Point-of Care Ultrasound for Patients With HIVNCT04246983 · lead sponsor · 2020-07-01

Physiological-based Cord Clamping in Congenital Diaphragmatic HerniaNCT04373902 · lead sponsor · 2020-05-11

HIV Indicator Diseases in Hospital and Primary CareNCT05225493 · lead sponsor · 2020-01-01

Defining the Potency of DTG/3TC for Suppressed HIV Patients in Real-life: the DUALING StudyNCT04707326 · lead sponsor · 2019-11-01

ACTIVE_NOT_RECRUITING

Prevalence of HCV in HIV-negative MSMNCT04005248 · lead sponsor · 2019-10-01

MYPP-trial: Myo-inositol Supplementation to Prevent Pregnancy Complications in Women With Polycystic Ovary Syndrome.NCT05524259 · lead sponsor · 2019-06-21

HRQOL in Prostate Cancer Patients Treated With RadiotherapyNCT05645237 · lead sponsor · 2019-04-08

ACTIVE_NOT_RECRUITING

Serial Multiparametric Evaluation of Right Ventricular Function After Left Ventricular Assist Device ImplantationNCT03552679 · lead sponsor · 2018-06-24

LRAs United as a Novel Anti-HIV Strategy.NCT03525730 · lead sponsor · 2018-04-18

MRI in PROstate Cancer Diagnosis With Prior Risk AssessmentNCT03225222 · lead sponsor · 2017-11-01

Potassium Supplementation in CKDNCT03253172 · lead sponsor · 2017-07-01

ACTIVE_NOT_RECRUITING

Status Asthmaticus on the PICU; Intravenous SalbutamolNCT03493503 · lead sponsor · 2017-04-05

RISAS Procedure in Node Positive Breast Cancer Following NACNCT02800317 · lead sponsor · 2017-03-30

Cabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs)NCT03050866 · lead sponsor · 2017-02-21

PULsecath mechanicaL Support EvaluationNCT03200990 · lead sponsor · 2016-12-01

Switching From Tenofovir Disoproxil Fumarate to Abacavir or Tenofovir AlafenamideNCT02957864 · lead sponsor · 2016-10-01

Status Asthmaticus on the Intensive Care Prospective - STATIC PRONCT02936778 · lead sponsor · 2016-08-01

Cabazitaxel in mCRPC Patients With AR-V7 Positive CTCsNCT02621190 · lead sponsor · 2016-02-01

Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCVNCT02600325 · lead sponsor · 2016-02-01

Treatment of HYpertension: Morning Versus EveningNCT02214498 · lead sponsor · 2015-05-01

Drugs studied in this sponsor's trials

37 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Erasmus Medical Center as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

placebo5

cabazitaxel2

dolutegravir2

tadalafil2

abacavir1

albuterol1

alectinib1

amiloride hydrochloride 5 MG Oral Tablet1

placebo RxCUI 8375 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 5 trials cabazitaxel RxCUI 996051 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials dolutegravir RxCUI 1433868 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 2 trials tadalafil RxCUI 358263 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials abacavir RxCUI 190521 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial albuterol RxCUI 435 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial alectinib RxCUI 1727455 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 1 trial amiloride hydrochloride 5 MG Oral Tablet RxCUI 977880 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial amlodipine RxCUI 17767 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial atezolizumab RxCUI 1792776 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial azithromycin RxCUI 18631 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial boceprevir RxCUI 1102129 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial carboplatin RxCUI 40048 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 1 trial chlorthalidone RxCUI 2409 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial dapagliflozin 10 MG RxCUI 1488565 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial darolutamide RxCUI 2180325 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial enalapril / hydrochlorothiazide RxCUI 214536 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial eplerenone RxCUI 298869 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial epoetin alfa RxCUI 105694 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial esmolol RxCUI 49737 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial everolimus RxCUI 141704 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial heparin RxCUI 5224 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial lenalidomide RxCUI 342369 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial lenalidomide 25 MG Oral Capsule RxCUI 643720 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor79

collaborator72

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.